Observational studyFrontiers in endocrinology2024

Synergistically improved cardiovascular outcomes in type 2 diabetes mellitus patients with combined treatment of SGLT-2 inhibitors and pioglitazone.

Yan-Rong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.